Market icon

Flu Hospitalization Rate Week 12, 2026?

Market icon

Flu Hospitalization Rate Week 12, 2026?

Apr. 3

Apr. 3

80–85 96%

85–90 1.0%

90–95 <1%

75–80 <1%

Polymarket
NEU

80–85 96%

85–90 1.0%

90–95 <1%

75–80 <1%

Polymarket
NEU

<75

$444 Vol.

<1%

75–80

$533 Vol.

1%

80–85

$3,608 Vol.

96%

85–90

$302 Vol.

1%

90–95

$3,798 Vol.

1%

95+

$293 Vol.

<1%

This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.The CDC's FluSurv-NET surveillance reported a preliminary cumulative influenza-associated hospitalization rate of 81.6 per 100,000 population for Week 11 (ending March 21, 2026)—the third highest at this stage since 2010-11—with weekly admissions dropping to 1.1 per 100k amid nationally declining flu activity, including outpatient visits at 2.9% (below baseline). FluSight ensemble models forecast minimal Week 12 additions of 0.93 new admissions per 100k (95% prediction interval: 0.29–2.19), projecting a final cumulative around 82.5 that aligns traders' overwhelming 95.5% consensus on the 80–85 bracket. This reflects epidemiological trends of waning seasonal transmission dominated by influenza A. Realistic challenges include upward data revisions from reporting lags or a late surge, though subdued hospital admissions (5,640 last week) make shifts outside 80–85 improbable; await the Week 12 FluView report next week.

This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.

If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.

The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.

Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Volumen
$8,978
Enddatum
3. Apr. 2026
Markt eröffnet
Mar 27, 2026, 11:13 AM ET

Resolver

0x69c47De9D...
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.The CDC's FluSurv-NET surveillance reported a preliminary cumulative influenza-associated hospitalization rate of 81.6 per 100,000 population for Week 11 (ending March 21, 2026)—the third highest at this stage since 2010-11—with weekly admissions dropping to 1.1 per 100k amid nationally declining flu activity, including outpatient visits at 2.9% (below baseline). FluSight ensemble models forecast minimal Week 12 additions of 0.93 new admissions per 100k (95% prediction interval: 0.29–2.19), projecting a final cumulative around 82.5 that aligns traders' overwhelming 95.5% consensus on the 80–85 bracket. This reflects epidemiological trends of waning seasonal transmission dominated by influenza A. Realistic challenges include upward data revisions from reporting lags or a late surge, though subdued hospital admissions (5,640 last week) make shifts outside 80–85 improbable; await the Week 12 FluView report next week.

This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.

If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.

The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.

Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Volumen
$8,978
Enddatum
3. Apr. 2026
Markt eröffnet
Mar 27, 2026, 11:13 AM ET

Resolver

0x69c47De9D...
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.

Vorsicht bei externen Links.

Häufig gestellte Fragen

„Flu Hospitalization Rate Week 12, 2026?" ist ein Prognosemarkt auf Polymarket mit 6 möglichen Ergebnissen, bei dem Händler Anteile auf Basis ihrer Einschätzung kaufen und verkaufen. Das aktuell führende Ergebnis ist „80–85" mit 96%, gefolgt von „75–80" mit 1%. Die Preise spiegeln Echtzeit-Wahrscheinlichkeiten der Community wider. Ein Anteilspreis von 96¢ bedeutet, dass der Markt diesem Ergebnis eine Wahrscheinlichkeit von 96% zuweist. Diese Quoten ändern sich laufend, wenn Händler auf neue Entwicklungen reagieren. Anteile am richtigen Ergebnis können bei Marktauflösung für jeweils $1 eingelöst werden.

„Flu Hospitalization Rate Week 12, 2026?" ist ein neu erstellter Markt auf Polymarket, gestartet am Mar 27, 2026. Als früher Markt haben Sie die Gelegenheit, zu den ersten Händlern zu gehören, die die Quoten setzen und die ersten Preissignale des Marktes etablieren. Sie können diese Seite auch als Lesezeichen speichern, um Volumen und Handelsaktivität zu verfolgen, während der Markt an Fahrt gewinnt.

Um auf „Flu Hospitalization Rate Week 12, 2026?" zu handeln, durchsuchen Sie die 6 verfügbaren Ergebnisse auf dieser Seite. Jedes Ergebnis zeigt einen aktuellen Preis, der die implizierte Wahrscheinlichkeit des Marktes darstellt. Um eine Position einzunehmen, wählen Sie das Ergebnis, das Sie für am wahrscheinlichsten halten, wählen Sie „Ja" um dafür oder „Nein" um dagegen zu handeln, geben Sie Ihren Betrag ein und klicken Sie auf „Handeln". Liegt Ihr gewähltes Ergebnis bei Marktauflösung richtig, zahlen Ihre „Ja"-Anteile jeweils $1 aus. Liegt es falsch, zahlen sie $0. Sie können Ihre Anteile auch jederzeit vor der Auflösung verkaufen.

Der aktuelle Favorit für „Flu Hospitalization Rate Week 12, 2026?" ist „80–85" mit 96%, was bedeutet, dass der Markt diesem Ergebnis eine Wahrscheinlichkeit von 96% zuweist. Das nächstliegende Ergebnis ist „75–80" mit 1%. Diese Quoten werden in Echtzeit aktualisiert, wenn Händler Anteile kaufen und verkaufen. Schauen Sie regelmäßig vorbei oder speichern Sie diese Seite als Lesezeichen.

Die Auflösungsregeln für „Flu Hospitalization Rate Week 12, 2026?" definieren genau, was passieren muss, damit jedes Ergebnis als Gewinner erklärt wird – einschließlich der offiziellen Datenquellen zur Bestimmung des Ergebnisses. Sie können die vollständigen Auflösungskriterien im Abschnitt „Regeln" auf dieser Seite über den Kommentaren einsehen. Wir empfehlen, die Regeln vor dem Handeln sorgfältig zu lesen, da sie die genauen Bedingungen, Sonderfälle und Quellen festlegen.